INDIANA
-
Allegion 2022 Health Care Trends Report Uncovers How Facilities Are Using Technology to Meet the Demands of Patients and Staff
The pandemic accelerated the adoption of new strategies and security measures to limit the spread of infection while protecting people and property CARMEL, Ind., April 5, 2022 /PRNewswire/ -- Today,
-
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2022 Financial Results
WARSAW, Ind., April 5, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Tuesday, May 3, 2022 at 8:30…
-
InventHelp Presents Public Sanitary Wipes (CCT-4570)
PITTSBURGH , April 4, 2022 /PRNewswire/ -- "During this pandemic I realized that many people touch door handles in order to enter or exit a public place, said the inventor from Jeffersonville, Ind. "I…
-
BIOSYNTHETIC® TECHNOLOGIES LAUNCHES INNOVATIVE NEW HIGH-PERFORMANCE 100% BIOBASED EMOLLIENT FOR COSMETIC AND PERSONAL CARE APPLICATIONS
INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Biosynthetic® Technologies, LLC today announced that it will launch its 100% biobased emollient for personal care applications; BioEstolide™ 250-100 at IN C…
-
Commercial Launch: Illuccix® Now Available to Order in the United States
MELBOURNE, Australia and INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that its prostate cancer imaging agent, Illuccix® (kit for p…
-
Corteva Announces Dates for First Quarter 2022 Earnings Release and Webcast
INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its first quarter 2022 earnings on Wednesday, May 4, after the stock market close via PR Newswire…
-
CNO Financial Group Announces the 2022 Invested in Giving Back® Charity Program Winners and Honors its Volunteer of the Year
CARMEL, Ind., April 1, 2022 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) today announced its 2022 Invested in Giving Back® program winners and CNO associate Meg Meek as its Volunteer...
-
Lilly Presents Updated Data on Retevmo® (selpercatinib) in Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer (NSCLC) at the 2022 European Lung Cancer Congress
INDIANAPOLIS, April 1, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 LIBRETTO-001 trial of Retevmo® (selpercatinib 40 mg & 80 mg capsules) in p…
-
Duke Energy supports economic development in Indiana with nearly $120,000 in grants
PLAINFIELD, Ind., March 31, 2022 /PRNewswire/ -- Duke Energy is awarding nearly $120,000 in strategic grants to 26 economic development groups to spur new jobs and investment across Indiana.
-
MetaCX Launches Initiatives to Enable Multi-Business Collaboration in the Metaverse
Initiatives by MetaCX enables collaboration with vendors, customers, and stakeholders on the collective achievement of your most strategic corporate objectives. INDIANAPOLIS, March 31, 2022 /PRNewswir…
-
hc1.com Inc. (hc1) Achieves HITRUST Risk-based, 2-Year (r2) Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
HITRUST Risk-based, 2-year Certification validates hc1 is committed to meeting key regulations and protecting sensitive information INDIANAPOLIS, March 31, 2022 /PRNewswire/ -- hc1.com Inc. (hc1), the…
-
ElectriCom LLC Announces Opening of Alpharetta, Georgia Regional Office
Ribbon Cutting Ceremony Held in Partnership with the Alpharetta Chamber of Commerce & City of Alpharett PAOLI, Ind., March 30, 2022 /PRNewswire/ -- ElectriCom LLC, a utility construction contractor fo…
-
Indiana's Manufacturing Companies Face New Challenges in Demand, Supply Chain, Workforce, and Automation as Pandemic Subsides, Survey Reveals
INDIANAPOLIS, March 30, 2022 /PRNewswire/ -- Katz, Sapper & Miller, a nationally recognized advisory, tax, and audit firm, has released the results of its annual manufacturing industry survey, "2022 I…
-
Corteva Agriscience Announces Reinstated Grower Access to Enlist® Herbicides for 2022 Growing Season
U.S. EPA Removes 134 County Restrictions, Issues Updated Supplemental Labels for Enlist One® and Enlist Duo® Herbicides INDIANAPOLIS, March 29, 2022 /PRNewswire/ -- Corteva Agriscience is pleased to a…
-
Hillenbrand named National STEM partner for Girls Inc.
-Hillenbrand investing to help develop the next generation of female leaders through Girls Inc. -Girls Inc. to leverage Hillenbrand's STEM leaders to influence next generation in career readiness BATE…
-
LRS KICKS OFF 2022 WITH TRANSFORMATIVE BOLT-ON ACQUISITION OF SOUTH BEND, IND.-BASED ROLL-OFF LEADER JUNOLL SERVICES, INCREASING ITS INVESTMENT IN THE VIBRANT MICHIANA REGION
Junoll acquisition expands LRS' northern Indiana offerings with the addition of new roll-off, Municipal Solid Waste, C&D and MSW transfer station services to complement existing regional portable rest…
-
Four-Star Basketball Prospect Jalen Hooks Announces Plans to Play for Lebron James AAU team "Strive For Greatness"
INDIANAPOLIS, March 28, 2022 /PRNewswire/ -- Four-star basketball player Jalen Hooks has announced his plans to play for AAU team "Strive For Greatness." Hooks, a 6-foot-7, 210-pound small forward, ma…
-
Shortage of Drivers May Make Roads Less Safe
Driver shortages result in more reckless accidents and make Indiana highways more dangerous says Stephenson Rife LLP SHELBYVILLE, Ind., March 28, 2022 /PRNewswire/ -- Mike Stephenson, personal injury…
-
Nearly 40% of Adults with Alopecia Areata Taking OLUMIANT® 4-mg Saw at Least 80% Scalp Hair Coverage at 52 Weeks in Lilly's Pivotal Phase 3 Studies
New England Journal of Medicine published OLUMIANT 36-week alopecia areata data today INDIANAPOLIS, March 26, 2022 /PRNewswire/ -- Adults with severe alopecia areata (AA) who took OLUMIANT® (baricitin…
-
Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Lebrikizumab rapidly improved skin and itch symptoms in four weeks INDIANAPOLIS, March 26, 2022 /PRNewswire/ -- More than 50 percent of patients with moderate-to-severe atopic dermatitis (AD) experien…